Entry Detail



General Information

Database ID:exR0012366
RNA Name:RPL8
RNA Type:mRNA
Chromosome:chr8
Starnd:-
Coordinate:
Start Site(bp):144789765End Site(bp):144792587
External Links:ENSG00000161016



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AHCY
chr20
34280268
34311802
-
ALDOA
chr16
30064164
30070457
+
AC124312.1
chr15
24955034
25000276
+
ACTB
chr7
5527148
5563784
-
AC105052.3
chr7
102637049
102671641
-
ALDH6A1
chr14
74056847
74084492
-
ADCK1
chr14
77800109
77935014
+
AC004922.1
chr7
99325879
99394653
+
ACTN1
chr14
68874143
68979440
-
AKIRIN1
chr1
38991276
39006059
+
AC092073.1
chr19
34396315
34409364
+
ADARB2
chr10
1177313
1737525
-
AIMP2
chr7
6009255
6023834
+
ACTN4
chr19
38647649
38731589
+
AC008982.1
chr19
38817471
38840178
-
AHSA1
chr14
77457870
77469472
+
ABHD12
chr20
25294742
25390835
-
AC027796.3
chr17
3585149
3636249
-
ACTG1
chr17
81509971
81523847
-
ACACA
chr17
37084992
37406836
-
ACTR5
chr20
38748460
38772520
+
ACTR2
chr2
65227753
65271253
+
AKAP8L
chr19
15380050
15419141
-
ADNP
chr20
50888916
50931437
-
AC011448.1
chr19
19516227
19536076
+
AL022238.4
chr22
40346529
40410054
+
AC018523.2
chr11
14493783
14520344
-
AGA
chr4
177430774
177442437
-
AC020909.1
chr19
50415799
50428409
+
ABHD17A
chr19
1876810
1885547
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-4751
chr19
49933073
49933096
+
hsa-miR-6850-5p
chr8
144791970
144791991
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005899.4
chr17
32328441
32329395
+
AC007952.4
chr17
19112000
19112636
-
AC016876.2
chr17
7581964
7584086
-
AC021242.3
chr8
9555144
9556520
-
AC026362.1
chr12
122975320
122982907
+
AC026461.1
chr16
56682470
56687807
+
AC060780.1
chr17
43148368
43171037
-
AC067930.1
chr8
143579636
143580670
+
AC092329.1
chr19
23257255
23274232
-
AC092329.4
chr19
23259906
23274251
-
AC099778.1
chr3
47379089
47380999
-
AC105105.1
chr18
58535415
58538552
+
AC105285.1
chr4
173094868
173169652
-
AC132217.1
chr11
2129121
2129964
-
AD000090.1
chr19
35557956
35581954
+
AL021707.1
chr22
38739003
38749041
+
AL022311.1
chr22
37876148
37895563
+
AL132780.1
chr14
22929607
22956374
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.